Q4 2021 Holdings
Filed 2022-02-11 | 55 holdings | $25.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $8.2M | 494,046 | 32.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.6M | 145,552 | 26.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $5.8M | 400,000 | 23.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $3.9M | 100,000 | 15.3% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $403.0K | 100,759 | 1.6% |
| Morphic Hldg Inc | COM | 61775R105 | $18.9K | 399,302 | 0.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $18.5K | 298,545 | 0.1% |
| Cassava Sciences Inc(SAVA)Put | COM | 14817C107 | $15.3K | 350,000 | 0.1% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $11.6K | 1,135,365 | 0.0% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $11.4K | 125,000 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $9.9K | 117,500 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $9.3K | 100,000 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $9.1K | 555,155 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $8.2K | 241,119 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $7.8K | 560,000 | 0.0% |
| Travere Therapeutics Inc | NOTE 2.500% 9/1 | 761299AB2 | $7.7K | $7,000,000 | 0.0% |
| Moderna Inc(MRNA)Put | COM | 60770K107 | $7.6K | 30,000 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $7.3K | 225,000 | 0.0% |
| Novavax Inc(NVAX)Put | COM NEW | 670002401 | $7.2K | 50,000 | 0.0% |
| Arya Sciences Acquisitn Corp | CLASS A ORD SHS | G31658100 | $6.8K | 702,500 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $5.7K | 271,778 | 0.0% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $5.5K | $7,500,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $5.5K | 65,000 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $5.4K | 1,049,721 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $5.2K | 77,500 | 0.0% |
| Curis Inc(CRISEUR)Call | COM NEW | 231269200 | $5.0K | 1,050,000 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $4.7K | 419,144 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.7K | 150,500 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $4.0K | 500,000 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $4.0K | 400,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.8K | 175,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $3.8K | 1,122,244 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $3.6K | 165,000 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $3.1K | 650,000 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $3.0K | 300,000 | 0.0% |
| Environmental Impact Acqu Co | COM CL A | 29408N106 | $3.0K | 300,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $2.9K | 20,000 | 0.0% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $2.9K | 300,000 | 0.0% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $2.5K | 100,000 | 0.0% |
| Science 37 Holdings Inc | COM | 808644108 | $1.9K | 150,000 | 0.0% |
| Curevac N VCall | COM | N2451R105 | $1.7K | 50,000 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $1.6K | 50,000 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $1.5K | 400,000 | 0.0% |
| ARK ETF TR(ARKG)Call | GENOMIC REV ETF | 00214Q302 | $1.5K | 25,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $1.2K | 10,000 | 0.0% |
| Seer Inc(SEER)Call | COM CL A | 81578P106 | $1.1K | 50,000 | 0.0% |
| Inovio Pharmaceuticals IncCall | COM NEW | 45773H201 | $998 | 200,000 | 0.0% |
| Renovacor Inc | COM | 75989E106 | $963 | 125,000 | 0.0% |
| Immatics N.v | *W EXP 07/01/2020 | N44445117 | $834 | 190,000 | 0.0% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $552 | 76,162 | 0.0% |